Societal costs and morbidity of pertussis in adolescents and adults.
about
Health-state valuations for pertussis: methods for valuing short-term health statesPertussis post-exposure prophylaxis among household contacts: a cost-utility analysisCost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic modelPertussis: Microbiology, Disease, Treatment, and Prevention.Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effectsUse of population health data to refine diagnostic decision-making for pertussisWhooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study.Acellular pertussis vaccines and the role of pertactin and fimbriae.Pertussis in Florida, 2000-2006: trends in a historically low-incidence stateSeroprevalence of pertussis in China: need to improve vaccination strategies.The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective studyCost-effectiveness analysis of Tdap in the prevention of pertussis in the elderlyRecommendation for the use of newly introduced Tdap vaccine in Korea.Survey and Rapid Detection of Bordetella pertussis in Clinical Samples Targeting the BP485 in ChinaPertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations.Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.Pertussis vaccination for health care workers.Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States.Pertussis: not only a disease of childhood.Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.Is adolescent pertussis vaccination preferable to natural booster infections?Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.Promoting Adult Pertussis Vaccination in the Workplace.Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012.[Vaccination in adults].Outbreak of pertussis among healthcare workers in a hospital surgical unit.Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.
P2860
Q24805972-315E9050-BBF6-4DF3-B450-51D2823E3577Q28543915-A0C51ECE-C7EC-4374-BAD6-DD0F17D2A79CQ28748851-1AC842CF-A0E6-4BF5-A1B9-1E9768A49DDCQ30251684-17D5B9A6-CF02-4CCA-BF9A-ECA0C4BC5379Q30375188-915EB2CA-02CB-4AAF-AE60-DD178C77A038Q30525482-93480B9E-15E9-4A27-B814-243D2507FF7AQ33156368-3596E2E3-9F4C-4CA8-B649-5346A92BD66EQ33482852-0C8F395A-F7B7-4FCE-8215-363A185BD270Q33523231-E3169705-0987-4A88-94B3-AC505F8BDE5CQ33801268-12302DB6-E783-4CC9-A431-B83FA0BB5828Q34002283-43F92C3E-9C55-4432-9165-EEDC88470290Q34077277-7E603165-D24B-4170-B48F-892B62F8B127Q34271536-70C34BB5-2C75-40A9-B209-14C1CE7735F5Q34560049-36EDBCDC-5826-4EB8-9B68-2BF59ECBEFB1Q34982647-A06B4D2C-5DF1-44F0-9634-03047E353065Q35079298-6A947F3B-B739-433F-948B-6651DB7C8836Q35149840-E46C3556-43C5-4DFC-B7C5-107365DF1B17Q36521834-F994C75F-256B-4213-8E4A-AA2D03165302Q36623553-E7F5EF8D-E0AE-4B02-8E90-2C36CDA6D764Q36803878-AC7970D2-4CC8-48CA-AE90-95EA1B40A76BQ37005179-E3B8C80B-09FE-4F2C-B141-DDECE625E417Q37188105-3576A6C2-7AB5-4667-A01B-CFE9FBC65F5EQ37458501-30CED2B9-EB62-46E0-AE96-DDBC49261829Q37960125-FDCF4DB7-353C-416E-8AFE-27C04E86CB51Q38626455-F2A22348-A5AE-4265-9EAA-983B39467294Q40480076-29C4D0B3-134B-4CBF-9C24-00EADAA22DD7Q40662504-A03DA97A-415F-4275-8385-581CA8A433F8Q42223770-87B1132C-806B-4A75-A2E7-B0B315BD006EQ51159206-A549ED21-AE7C-43B2-A4CE-C9AD6F1E64CBQ51186400-6B58E44C-D970-4AE5-8413-9EE511E2DDFBQ52569035-87E88A20-E85F-49B6-90CD-B47D1289D3E0
P2860
Societal costs and morbidity of pertussis in adolescents and adults.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Societal costs and morbidity of pertussis in adolescents and adults.
@en
type
label
Societal costs and morbidity of pertussis in adolescents and adults.
@en
prefLabel
Societal costs and morbidity of pertussis in adolescents and adults.
@en
P2093
P356
P1476
Societal costs and morbidity of pertussis in adolescents and adults.
@en
P2093
Charles LeBaron
Donna Rusinak
Grace M Lee
Massachusetts Pertussis Study Group
Stephanie Schauer
Susan Lett
Tracy A Lieu
Trudy V Murphy
P304
P356
10.1086/425006
P407
P577
2004-11-10T00:00:00Z